LENSAR (NASDAQ:LNSR – Get Rating) and TELA Bio (NASDAQ:TELA – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, dividends, risk, institutional ownership and earnings. Valuation & Earnings This table compares LENSAR and TELA Bio’s […]
TELA Bio (NASDAQ:TELA – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Tuesday, Zacks.com reports. According to Zacks, “TELA Bio Inc. is a commercial stage medical technology company. It is focused on the designing, developing and marketing of tissue reinforcement materials […]
TELA Bio, Inc. (NASDAQ:TELA – Get Rating) insider Ew Healthcare Partners Fund 2, acquired 5,000 shares of TELA Bio stock in a transaction that occurred on Thursday, March 31st. The shares were purchased at an average cost of $11.54 per share, for a total transaction of $57,700.00. The transaction was disclosed in a legal filing […]
TELA Bio, Inc. (NASDAQ:TELA – Get Rating) insider Ew Healthcare Partners Fund 2, acquired 3,052 shares of TELA Bio stock in a transaction on Tuesday, March 29th. The stock was acquired at an average cost of $11.65 per share, for a total transaction of $35,555.80. The transaction was disclosed in a legal filing with the […]
TELA Bio, Inc. (NASDAQ:TELA – Get Rating) – Equities researchers at Jefferies Financial Group cut their Q1 2022 EPS estimates for TELA Bio in a report released on Monday, March 21st. Jefferies Financial Group analyst Z. Weiner now anticipates that the company will post earnings of ($0.44) per share for the quarter, down from their […]